Thalamic neurodegeneration in multiple sclerosis

A Cifelli, M Arridge, P Jezzard, MM Esiri… - Annals of Neurology …, 2002 - Wiley Online Library
Multiple sclerosis is still regarded primarily as a disease of the white matter. However, recent
evidence suggests that there may be significant involvement of gray matter. Here, we have …

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease

…, EB Johnson, PA Wijeratne, M Arridge… - Science translational …, 2020 - science.org
The longitudinal dynamics of the most promising biofluid biomarker candidates for
Huntington’s disease (HD)—mutant huntingtin (mHTT) and neurofilament light (NfL)—are …

[HTML][HTML] Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease

…, R Tortelli, EB Johnson, MS Foiani, M Arridge… - Scientific Reports, 2021 - nature.com
Brain-derived neurotrophic factor (BDNF) is implicated in the survival of striatal neurons.
BDNF function is reduced in Huntington’s disease (HD), possibly because mutant huntingtin …

Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington's disease: The prospective HD-CSF study

…, R Tortelli, EB Johnson, PA Wijeratne, M Arridge… - medRxiv, 2020 - medrxiv.org
The longitudinal dynamics of the most promising biofluid biomarker candidates for
Huntington’s disease (HD) – mutant huntingtin (mHTT) and neurofilament light (NfL) – are …

Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease

AJ Lowe, FB Rodrigues, M Arridge… - Brain …, 2022 - academic.oup.com
Proton magnetic resonance spectroscopy is a non-invasive method of exploring cerebral
metabolism. In Huntington’s disease, altered proton magnetic resonance spectroscopy-…

E05 Longitudinal evaluation of magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease

AJ Lowe, FB Rodrigues, M Arridge, E De Vita… - 2022 - jnnp.bmj.com
Background Magnetic resonance spectroscopy (MRS) is a non-invasive method of exploring
cerebral metabolism. In Huntington’s disease (HD), altered concentrations of several …

Identification of an essential endogenous regulator of blood–brain barrier integrity, and its pathological and therapeutic implications

…, IA Romero, M Wylezinska-Arridge… - Proceedings of the …, 2013 - National Acad Sciences
The blood–brain barrier (BBB), a critical guardian of communication between the periphery
and the brain, is frequently compromised in neurological diseases such as multiple sclerosis (…

CXCR4‐targeted and MMP‐responsive iron oxide nanoparticles for enhanced magnetic resonance imaging

…, QD Nguyen, M Wylezinska‐Arridge… - Angewandte Chemie …, 2014 - Wiley Online Library
MRI offers high spatial resolution with excellent tissue penetration but it has limited sensitivity
and the commonly administered contrast agents lack specificity. In this study, two sets of …

Liver Fat Content and T2*: Simultaneous Measurement by Using Breath-hold Multiecho MR Imaging at 3.0 T—Feasibility1

DP O'Regan, MF Callaghan, M Wylezinska-Arridge… - Radiology, 2008 - pubs.rsna.org
Research ethics committee approval was obtained for this study, and written informed
consent was obtained from all participants. The purpose was to prospectively evaluate the …

Direct synthesis of dextran-coated superparamagnetic iron oxide nanoparticles in a capillary-based droplet reactor

…, N Kamaly, M Wylenzinska-Arridge… - Journal of Materials …, 2012 - pubs.rsc.org
We describe the controlled synthesis of dextran-coated superparamagnetic iron oxide
nanoparticles (SPIONs) using a stable passively-driven capillary-based droplet reactor. High …